臨床呼吸器疾患とケアのジャーナル: オープンアクセス

Tuberculosis and Cystic Fibrosis: Understanding the Intersection of Two Respiratory Challenges

Abstract

Aleksandra Mikos

Tuberculosis (TB) and Cystic Fibrosis (CF) are two distinct yet significant respiratory conditions that affect millions of people worldwide. While they differ in their origins, symptoms and treatments, the intersection of TB and CF poses unique challenges for individuals who face both conditions simultaneously. Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis, a pathogen that primarily affects the lungs but can potentially target other organs in the body. TB has been a significant public health concern for centuries and continues to impact millions of people worldwide. To better understand this infectious disease, let's delve into its causes, transmission, symptoms, diagnosis and treatment. Cystic Fibrosis, on the other hand, is a genetic disorder characterized by the production of thick and sticky mucus that clogs the airways and various organs, particularly the lungs and pancreas. The defective gene responsible for CF affects the body's ability to regulate salt and water, leading to the accumulation of thick mucus. Symptoms include chronic cough, difficulty breathing, frequent lung infections and poor growth.